Interactive Research Tools
Incretin + Amylin Tools
Two interactive tools for the drug pairings that put a GLP-1-based incretin alongside an amylin analog, the way CagriSema pairs cagrilintide with semaglutide and EloraTZP pairs eloralintide with tirzepatide: the full receptor footprint of a combination, and how both molecules rise and fall across a shared dosing schedule.
Receptor Footprint
A Combination at the Receptor
Dial an incretin and an amylin together and see the whole footprint: the GLP-1, GIP, and glucagon receptors on the incretin side, and the AMY1, AMY3, and calcitonin receptors on the amylin side, each against the highest dose tested in trials.
Open the receptor tool →
Dose-Curve
Combination Dose-Curve Visualizer
Plot the medication level of an incretin and an amylin on one weekly timeline and watch both climb to steady state together, with presets for CagriSema, EloraTZP, and retatrutide-plus-amylin pairings.
Open the dose-curve tool →
Research use only · Not medical advice · Models, not a dosing recommendation
Brand names (Ozempic, Wegovy, Zepbound, Mounjaro, Victoza, Saxenda, Symlin) are registered trademarks of their respective owners, used here for identification only. Cagrilintide, eloralintide, petrelintide, amycretin, survodutide, cotadutide, and retatrutide are investigational and not approved for any use. These tools are not affiliated with or endorsed by any manufacturer.